Literature DB >> 9720519

Partial nephrectomy for renal cell carcinoma can achieve long-term tumor control.

H Van Poppel1, B Bamelis, R Oyen, L Baert.   

Abstract

PURPOSE: Partial nephrectomy is becoming more widely accepted as alternative treatment for small renal cell carcinoma. To analyze its value in tumor control and its complication rate a retrospective study was done.
MATERIALS AND METHODS: A total of 76 patients underwent kidney sparing surgery, which was required in 25 and in the presence of a normal contralateral kidney in 51. Tumor size varied between 0.9 and 15 cm. Simple enucleation was done in 4 and partial nephrectomy in all other cases. The patients were followed every 3 months during year 1, every 4 months during years 2 and 3, and every 6 months during years 4 and 5 postoperatively. Mean followup is 75 months.
RESULTS: Eight patients had postoperative complications, most often hemorrhage. None of the patients had local recurrence, although in 3 systemic disease developed.
CONCLUSIONS: Nephron sparing surgery is more challenging than radical nephrectomy and, therefore, can be more complicated. The selection of suitable candidates is the key to success. Many patients can benefit from nephron sparing surgery for small easily resectable renal cell carcinoma even in presence of a normal contralateral kidney. Randomized trials are needed to establish the definitive role of this approach in kidney cancer treatment.

Entities:  

Mesh:

Year:  1998        PMID: 9720519     DOI: 10.1097/00005392-199809010-00007

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  26 in total

1.  Endovascular management of iatrogenic renal arterial lesions and clinical outcomes.

Authors:  Serkan Güneyli; Mustafa Gök; Halil Bozkaya; Celal Çınar; Arastu Tizro; Mehmet Korkmaz; Yiğit Akın; Mustafa Parıldar; İsmail Oran
Journal:  Diagn Interv Radiol       Date:  2015 May-Jun       Impact factor: 2.630

2.  Renal cell carcinoma: diagnosis and treatment, 1994-2003.

Authors:  Thomas E Hutson
Journal:  Proc (Bayl Univ Med Cent)       Date:  2005-10

Review 3.  Open partial nephrectomy: ancient art or currently available technique?

Authors:  Mauro Seveso; Fabio Grizzi; Giorgio Bozzini; Alberto Mandressi; Giorgio Guazzoni; Gianluigi Taverna
Journal:  Int Urol Nephrol       Date:  2015-10-05       Impact factor: 2.370

4.  Advances of multidetector computed tomography in the characterization and staging of renal cell carcinoma.

Authors:  Athina C Tsili; Maria I Argyropoulou
Journal:  World J Radiol       Date:  2015-06-28

Review 5.  [Recurrent disease in renal cell carcinoma. "Local recurrence" after kidney-sparing and radical resection].

Authors:  M Löhr; D Rohde
Journal:  Urologe A       Date:  2005-04       Impact factor: 0.639

6.  Risk factors for postoperative hemorrhage after partial nephrectomy.

Authors:  Saebin Jung; Gyeong Eun Min; Benjamin I Chung; Seung Hyun Jeon
Journal:  Korean J Urol       Date:  2014-01-15

7.  Phase I/II trial of 5-fluorouracil and a noncytotoxic dose level of suramin in patients with metastatic renal cell carcinoma.

Authors:  Saby George; Robert Dreicer; Jessie J L Au; Tong Shen; Brian I Rini; Susan Roman; Matthew M Cooney; Tarek Mekhail; Paul Elson; Guillaume M Wientjes; Ram Ganapathi; Ronald M Bukowski
Journal:  Clin Genitourin Cancer       Date:  2008-09       Impact factor: 2.872

Review 8.  Oncological outcomes of partial nephrectomy for tumours larger than 4 cm: A systematic review.

Authors:  Tarek H El-Ghazaly; Ross J Mason; Ricardo A Rendon
Journal:  Can Urol Assoc J       Date:  2014-01       Impact factor: 1.862

9.  Management of renal tumors by image-guided radiofrequency ablation: experience in 105 tumors.

Authors:  David J Breen; Elizabeth E Rutherford; Brian Stedman; Shuvro H Roy-Choudhury; James E I Cast; Matthew C Hayes; Christopher J Smart
Journal:  Cardiovasc Intervent Radiol       Date:  2007-06-18       Impact factor: 2.740

10.  Nephron sparing surgery: A single institution experience.

Authors:  S Agrawal; M S Jha; N Khurana; M S A Ansari; D Dubey; A Srivastava; R Kapoor; A Kumar; M Jain; A Mandhani
Journal:  Indian J Urol       Date:  2007-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.